Industry

WHITE PLAINS, N.Y.–(BUSINESS WIRE)–The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its second quarter 2022 financial results on Monday, August 8, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T. Conference … [Read more…]

Aural Analytics’ Speech Vitals technology delivers clinical-grade speech analytics PHOENIX–(BUSINESS WIRE)–#AuralAnalytics–Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today it was awarded a $1.4 million grant from the National Institutes of Health. The grant supports Aural Analytics’ development of a tool speech-language pathologists can use to improve their clinical workflow. “The timing of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Fractional Flow Reserve Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing stent insertion, … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that it has made an amendment to the terms of the non-brokered Private Placement previously announced in its News Release dated June 30, 2022. The private placement is being offered to accredited investors to raise up to $4 million … [Read more…]

SG Blocks and Clarity Lab Solutions joint venture, Clarity Mobile Venture, received an extension for COVID-19 testing at its Los Angeles International Airport location. JACKSONVILLE, Fla.–(BUSINESS WIRE)–SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading developer, designer, and fabricator of modular structures, announced today that Clarity Mobile Venture, a partnership with Clarity … [Read more…]

This updated version of the Inscopix Data Exploration, Analysis and Sharing (IDEAS) Platform has added features and tools for neural circuit insights including peri-event analysis. MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#FENS–Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that it is launching the Inscopix Data Exploration, Analysis and Sharing (IDEAS) Platform to … [Read more…]

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2022 financial results on Wednesday, Aug. 3, 2022. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at http://ir.horizontherapeutics.com. Please connect … [Read more…]

WALTHAM, Mass. & MONTREAL–(BUSINESS WIRE)–Ventus Therapeutics, Inc., a biopharmaceutical company leading a renaissance in the discovery and development of small molecule medicines by utilizing structural biology and a proprietary computational platform, today announced the promotion of Daniel Koerwer from Chief Business Officer to Chief Operating Officer. In this new role, in addition to corporate and … [Read more…]

— Company shares proprietary and scalable approach using human derived organoids for preclinical pharmacodynamic (PD) assessment of drugs targeting podocyte cells — — Recent preliminary data from Phase 2 study of GFB-887 in focal segmental glomerular disease (FSGS) further validate feasibility and value of using transplanted human organoids in preclinical PD studies — CAMBRIDGE, Mass.–(BUSINESS … [Read more…]